Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
icosapent ethyl (vascepa) (3 trials)
fish oil (Omegavan) (2 trials)
immune globulin (human) (Gamastan) (1 trial)
greenshell mussel extract (1 trial)
ashwagandha extract (1 trial)
astaxanthin (1 trial)
cannabidiol (Epidiolex) (1 trial)
creatine (1 trial)
inulin (1 trial)
inulinase (1 trial)
magnesium sulfate (Tis-U-Sol) (1 trial)
maltodextrin (1 trial)
multivitamins (1 trial)
nicotinamide (1 trial)
oligo fucoidan (1 trial)
olive (1 trial)
pterostilbene (1 trial)
resistant starch (1 trial)
turmeric (1 trial)
xylooligosaccharide (1 trial)
Hyperlipidemia, Familial Combined (Phase 4)
Hyperlipidemias (Phase 4)
Hyperlipoproteinemias (Phase 4)
Hyperlipoproteinemia Type V (Phase 4)
Lipidoses (Phase 4)
Trials (19 total)
Trial APIs (20 total)